Navigation Links
Ben-Gurion University of the Negev receives $450,000 grant to conduct oil and natural gas research
Date:8/8/2012

BEER-SHEVA, ISRAEL, August 8, 2012 Ben-Gurion University of the Negev (BGU) researchers have received a $450,000 grant (290,000) from the Wolfson Family Charitable Trust and Wolfson Foundation for projects related to oil and gas generation and its environmental impact.

According to BGU's Vice President for Research and Development Prof. Moti Herskowitz, these two projects are part of the University's overall commitment to research alternative energy sources and cleaner technologies. "This support reflects BGU's leadership role in alternative energy research in Israel thanks to its multidisciplinary approach," says Herskowitz, who is also the founder and director of the BGU Blechner Center for Industrial Catalysis and Process Development.

One of the grant projects being conducted at the Blechner Center is focused on using a novel method for conversion of natural gas to syngas through catalytic partial oxidation for downstream treatment of natural gas. The researchers believe that this process provides significant opportunities for commercial production.

The other project involves tracking oil and gas formation in a variety of environments, source rocks and generation mechanisms, through the investigation of sulfur and short hydrocarbon transformations using molecular and isotopic geochemical approach. The research will be conducted by BGU's Department of Geology and Environmental Sciences to help improve the understanding of oil and gas generation and their environmental impact.

"BGU has a worldwide reputation for its research and innovation in alternative energy, and now, this grant will further Israel's position in reducing worldwide reliance on oil, as part of the BGU energy initiative," says Doron Krakow, executive vice president of American Associates, Ben-Gurion University of the Negev.


'/>"/>

Contact: Andrew Lavin
andrewlavin@alavin.com
516-944-4486
American Associates, Ben-Gurion University of the Negev
Source:Eurekalert

Page: 1

Related biology news :

1. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
2. Sleep deprivation may reduce risk of PTSD according to Ben-Gurion U. researchers
3. University of Houston study shows BP oil spill hurt marshes, but recovery possible
4. University of Alberta led research may have discovered how memories are encoded in our brains
5. BGI, University of Helsinki and Wuhan University sign a MOU concerning cooperation on genomics
6. Marshall University study may lead to new treatments for prostate cancer
7. University leads £6 million EU project to tackle obesity
8. A University of Tennessee professors hypothesis may be game changer for evolutionary theory
9. Life expectancy may affect when you get married, divorced, have kids: Queens University study
10. University of Toronto biologists predict extinction for organisms with poor quality genes
11. University of Minnesota invention helps advance reliability of alternative energy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... -- According to a new market research report "Emotion Detection and ... Recognition), Service, Application Area, End User, And Region - Global Forecast to 2021", ... Billion in 2016 to USD 36.07 Billion by 2021, at a Compound Annual ... ... MarketsandMarkets Logo ...
(Date:12/7/2016)... 7, 2016   Avanade is helping Williams ... teams in history, exploit biometric data in order to ... maintain the competitive edge against their rivals after their ... Avanade has worked with Williams during the 2016 ... data (heart rate, breathing rate, temperature and peak acceleration) ...
(Date:12/6/2016)... , Dec. 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE ... priced an offering of €500.0 million principal amount of its ... amount of its 2.425% senior unsecured notes due 2026. ... occur on December 13, 2016, subject to the satisfaction of customary ... basis. The Company intends to ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Renova™ Therapeutics, a ... heart failure and type 2 diabetes, announced that ... novel adeno-associated virus (AAV) vector developed in the ... Ph.D., at Stanford University. The company plans to ... gene therapy product pipeline. "Early ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... SDK that provide essential device-to-computer interconnect using USB or PCI Express, announced the ... support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits a standard ...
(Date:12/8/2016)... 2016  Anaconda BioMed S.L., a pre-clinical stage medical ... generation neuro-thrombectomy system for the treatment of Acute Ischemic ... MD to join its Scientific Advisory Board (SAB). The ... of scientific and clinical experts to Anaconda BioMed S.L., ... BRAIN ® to its clinical phase. The SAB ...
(Date:12/8/2016)... ... December 08, 2016 , ... Microbial genomics leader, ... uBiome is one of just six company finalists in the Health & Medicine ... uBiome, companies nominated as finalists in this year’s awards include Google, SpaceX, Oculus, ...
Breaking Biology Technology: